alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II 

117TH CONGRESS 

2D SESSION S. 3954 

To amend the Federal Reserve Act to prohibit the Federal reserve banks 

from offering certain products or services directly to an individual, and 

for other purposes. 

IN THE SENATE OF THE UNITED STATES 

MARCH 30, 2022 

Mr. CRUZ (for himself, Mr. BRAUN, and Mr. GRASSLEY) introduced the following bill; which was read twice and referred to the Committee on Banking, Housing, and Urban Affairs 

A BILL 

To amend the Federal Reserve Act to prohibit the Federal 

reserve banks from offering certain products or services 

directly to an individual, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PROHIBITION ON FEDERAL RESERVE BANKS 

4 RELATING TO CERTAIN PRODUCTS OR SERV5 ICES FOR INDIVIDUALS. 

6 Section 13 of the Federal Reserve Act is amended 

7 by adding after the 14th undesignated paragraph (12 

8 U.S.C. 347d) the following: 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 3954 IS

1 ‘‘No Federal reserve bank may offer products 

2 or services directly to an individual, maintain an ac3 count on behalf of an individual, or issue a central 

4 bank digital currency directly to an individual.’’. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
<PAGE>


                                   EXHIBIT 11

                           DURA PHARMACEUTICALS, INC.
            STATEMENTS RE COMPUTATIONS OF NET INCOME (LOSS) PER SHARE


<TABLE>
<CAPTION>

                                                              1999                1998                1997
                                                        ------------------  ------------------  ------------------
<S>                                                     <C>                 <C>                 <C>
NET INCOME PER SHARE - BASIC

Net income                                               $   30,004,000      $     2,733,000     $   (84,692,000)
                                                        ==================  ==================  ==================

Weighted average number of common shares:
      Common stock                                            44,132,372          46,028,396          43,828,208
                                                        ==================  ==================  ==================

Net income per share                                     $          0.68     $          0.06     $         (1.93)
                                                        ==================  ==================  ==================

NET INCOME PER SHARE - DILUTED

Net income                                               $    30,004,000     $     2,733,000     $   (84,692,000)
                                                        ==================  ==================  ==================


Weighted average number of common and
   common equivalent shares assuming
   issuance of all dilutive contingent shares:
      Common stock                                            44,132,372          46,028,396          43,828,208
      Stock options                                              906,859             744,155                   -
      Warrants                                                   633,070           1,036,440                   -
                                                        ------------------  ------------------  ------------------
         Total                                                45,672,301          47,808,991          43,828,208
                                                        ==================  ==================  ==================

Net income per share                                     $          0.66     $          0.06     $         (1.93)
                                                        ==================  ==================  ==================

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE CONDENSED CONSOLIDATED STATEMENT OF INCOME (LOSS) AND THE CONDENSED
CONSOLIDATED BALANCE SHEET AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          NOV-30-1997
<PERIOD-START>                             MAR-01-1997
<PERIOD-END>                               MAY-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                        242,183
<TOTAL-REVENUES>                               242,183
<CGS>                                          194,578
<TOTAL-COSTS>                                  194,578
<OTHER-EXPENSES>                                34,341
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,924
<INCOME-PRETAX>                                  4,993
<INCOME-TAX>                                     4,448
<INCOME-CONTINUING>                                545
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       545
<EPS-PRIMARY>                                      .05
<EPS-DILUTED>                                      .05
        

</TABLE>
**EXHIBIT 32.1**

 

CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with theQuarterly Report of bebe stores, inc. (the “Company”) on Form 10-Q for thequarter ended October 2, 2004, as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Gregory Scott, Chief ExecutiveOfficer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on myknowledge:

 

(1)   The Quarterly Report fully complies with therequirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C.78m); and

 

(2)   The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 
| Dated: November 5, 2004 | /s/ Gregory Scott       |   |
|-------------------------|-------------------------|--------|
|                    | Gregory Scott           |
|                    | Chief Executive Officer |

 

1

----
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                           AND CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      I, Dennis Calvert, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the amended
Annual Report of NuWay, Inc. on Form 10-KSB/A for the fiscal year ended December
31, 2005 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 and that information contained in such Annual
Report on Form 10-KSB/A fairly presents in all material respects the financial
condition and results of operations of NuWay Medical, Inc.


Dated:   April 28, 2006                By: /s/ Dennis Calvert
                                           -------------------------------------
                                           Dennis Calvert
                                           President and Chief Executive Officer

      A signed original of this written statement required by Section 906 has
been provided to NuWay Medical, Inc. and will be retained by NuWay Medical, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.

      I, Dennis Calvert, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the amended
Annual Report of NuWay Medical, Inc. on Form 10-KSB/A for the fiscal year ended
December 31, 2003 fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934 and that information contained in such
Annual Report on Form 10-KSB/A fairly presents in all material respects the
financial condition and results of operations of NuWay Medical, Inc.


Dated:   April 28, 2006                By: /s/Dennis Calvert
                                           -------------------------------------
                                           Dennis Calvert
                                           Interim Chief Financial Officer

      A signed original of this written statement required by Section 906 has
been provided to NuWay Medical, Inc. and will be retained by NuWay Medical, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MAY 3, 2024

NO. 03-22-00198-CV

UnitedHealthcare Insurance Company and Sierra Health and Life Insurance 

Company, Inc., Appellants

v.

Ken Paxton, Attorney General of Texas; Teacher Retirement System of Texas; 

Humana Insurance Company; Humana Insurance Company of New York; and 

Humana Insurance Company of Puerto Rico, Inc., Appellees

APPEAL FROM THE 53RD DISTRICT COURT OF TRAVIS COUNTY

BEFORE CHIEF JUSTICE BYRNE, JUSTICES TRIANA AND SMITH

AFFIRMED -- OPINION BY JUSTICE SMITH

This is an appeal from the judgment signed by the trial court on April 2, 2022. Having reviewed 

the record and the parties’ arguments, the Court holds that there was no reversible error in the 

trial court’s judgment. Therefore, the Court affirms the trial court’s judgment. The appellants

shall pay all costs relating to this appeal, both in this Court and in the court below.
[Federal Register Volume 60, Number 39 (Tuesday, February 28, 1995)]
[Sunshine Act Meetings]
[Page 10897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-5073]



-----------------------------------------------------------------------


Commodity Futures Trading Commission.

time and date: 11:00 a.m., Friday, March 24, 1995.

place: 2033K St., N.W., Washington, D.C. 8th Floor Hearing Room.

status: Closed.

matters to be considered: Surveillance Matters.

contact person for more information: Jean A. Webb, 202-254-6314.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 95-5073 Filed 2-24-95; 3:28 pm]
BILLING CODE 6351-01-M
[Federal Register Volume 60, Number 31 (Wednesday, February 15, 1995)]
[Notices]
[Page 8661]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3756]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration on Aging


White House Conference on Aging

AGENCY: White House Conference on Aging, AoA, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given, pursuant to Title II of the Older 
Americans Act Amendments of 1987, Pub. L. 100-175 as amended by Pub. L. 
102-375 and Pub. L. 103-171, that the 1995 White House Conference on 
Aging Advisory Committee will hold a meeting on Friday, March 3, 1995, 
from 9 AM to 11 AM. The meeting will be held at the Marriott Metro 
Center Hotel, 775 12th Street NW., Washington, DC.
    The meeting of the Committee shall be open to the public. The 
proposed agenda includes a discussion of the responsibilities of the 
Advisory Committee for the Conference.
    Records shall be kept of all Committee proceedings and shall be 
available for public inspection at 501 School Street SW., 8th Floor, 
Washington, DC 20024.

FOR FURTHER INFORMATION CONTACT:
White House Conference on Aging, 501 School Street SW., 8th Floor, 
Washington, DC 20024; telephone (202) 245-7116.

    Dated: February 9, 1995.
Fernando M. Torres-Gil,
Assistant Secretary for Aging.
[FR Doc. 95-3756 Filed 2-14-95; 8:45 am]
BILLING CODE 4130-02-M
## COURT OF APPEALS

SECOND DISTRICT OF TEXAS FORT WORTH

NO. 02

- 15

- 00320

- CV

JORGE CHAVARRIA, BRA NDY CHAVARRIA, AND WILMA SOLORAZANO APPELLANTS

V.

PRESTONWOOD DRIVE 2737 LAND TRUST APPELLEE

------------

FROM COUNTY COURT AT LAW NO. 2 OF DENTON C OUNTY TRIAL COURT NO. CV

- 2015

- 01562

------------



### MEMORANDUM OPINION 1 

### AND JUDGMENT

------------

On October 13, 2015

, and November 2, 2015, we notified appellant s in

accordance with rule of appellate procedure 42.3(c) that we would dismiss this

appeal unle ss the $ 205 filing fee was paid. See Tex. R. App. P. 42.3(c).

Appellant s have not paid the $ 205 filing fee. See Tex. R. App. P. 5, 12.1(b).

1 See Tex. R. App. P. 47.4.2 Because appellant s failed to comply with a requirement of the rules of

appellate procedure and the Texas Supreme Court ’s order of August 28

, 2015

, 2

we dismiss the appeal. See Tex. R. App. P. 42.3(c), 43.2(f).

Appellant s shall pay all costs of this appeal, for which let execution issue.

See Tex. R. App. P. 43.4.

PER CURIAM

PANEL: LIVINGSTON, C.J.; DAUPHINOT and GAR DNER, JJ.

DELIVERED: November 25, 2015

2 See Supreme Court of Tex., Fees Charged in the Supreme Court, in Civil Cases in the Courts of Appeals, and Before the Judicial Panel on Multi

- district Litigation

, Misc. Docket No. 15

- 915 8 (Aug. 28, 2015) (listing courts of appeals ’ fees).
# Fourth Court of Appeals

**San Antonio, Texas**

JUDGMENT

No. 04

- 15

- 00771

- CR

John David GARCIA

, Appellant

v.

The STATE of Texas,

Appellee

From the 81st Judicial District Court, Wilson County, Texas

Trial Court No. 11

- 05

- 075

- CRW

Honorable Russell Wilson, Judge Presiding

BEFORE JUSTICE MARTINEZ

, JUSTICE ALVAREZ , AND JUSTICE CHAPA

In accordance with this court’s opinion of this date, the judgment of the trial court is

AFFIRMED.

SIGNED February 1, 2017.

_____________________________ Luz Elena D. Chapa, Justice
#### In the Matter of Leslie Otero, Petitioner, v Glenn S. Goord, as Commissioner of Correctional Services, Respondent.

[772 NYS2d 882]

Proceeding pursuant to CPLR article 78 (transferred to this Court by order of the Supreme Court, entered in Albany County) to review a determination of respondent which found petitioner guilty of violating a prison disciplinary rule.

Petitioner commenced this CPLR article 78 proceeding challenging a determination finding him guilty of violating urinalysis testing procedures. The Attorney General has advised this Court by letter that the determination at issue has been administratively reversed and that all references thereto have been expunged from petitioner’s institutional record. Inasmuch as petitioner has received all the relief to which he is entitled and is no longer aggrieved, the matter is dismissed as moot *(see Matter of Bellini v Goord,*309 AD2d 1139 [2003]).

Cardona, P.J., Mercure, Carpinello, Rose and Lahtinen, JJ., concur. Adjudged that the petition is dismissed, as moot, without costs.
[Federal Register Volume 60, Number 33 (Friday, February 17, 1995)]
[Notices]
[Pages 9333-9334]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3981]



-----------------------------------------------------------------------


FEDERAL MARITIME COMMISSION

Notice of Agreement(s) Filed

    The Federal Maritime Commission hereby gives notice of the filing 
of the following agreement(s) pursuant to section 5 of the Shipping Act 
of 1984.
    Interested parties may inspect and obtain a copy of each agreement 
at the Washington, DC Office of the Federal Maritime Commission, 800 
North [[Page 9334]] Capitol Street, NW., 9th Floor. Interested parties 
may submit comments on each agreement to the Secretary, Federal 
Maritime Commission, Washington, DC 20573, within 10 days after the 
date of the Federal Register in which this notice appears. The 
requirements for comments are found in Sec. 572.603 of Title 46 of the 
Code of Federal Regulations. Interested persons should consult this 
section before communicating with the Commission regarding a pending 
agreement.
    Agreement No.: 202-011432-003.
    Title: Pacific Latin America Agreement.
    Parties:

    Sea-Land Service, Inc.
    Central American Container Line, S.A.
    A.P. Moller-Maersk Line

    Synopsis: The proposed amendment deletes Central America Container 
Line, S.A., changes the notification period for independent action from 
two days to five days and authorizes the Conference Chairman or his 
designee to sign and file any amendments to the basic Agreement.

    Dated: February 13, 1995.

    By Order of the Federal Maritime Commission.
Joseph C. Polking,
Secretary.
[FR Doc. 95-3981 Filed 2-16-95; 8:45 am]
BILLING CODE 6730-01-M
[Federal Register Volume 60, Number 42 (Friday, March 3, 1995)]
[Notices]
[Page 11996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-5266]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application

    Pursuant to Section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under Section 1002(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Section 1311.42 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on January 19, 
1995, Abbott Laboratories, IMP, Attn: Plant Manager, U.S. Highway 301 
N., Rocky Mount, North Carolina 27801, made a written request to the 
Drug Enforcement Administration to be registered as an importer of 
Meperidine (9230) a basic class of controlled substance in Schedule II.
    The firm will import the Meperidine to produce vials for a patient 
controlled analgesia pump.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of this basic class of controlled substance may file 
written comments on or objection to the application described above and 
may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.54 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than (30 days from 
publication).
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1311.42 (b), (c), 
(d), (e), and (f). As noted in a previous notice at 40 FR 43745-46 
(September 23, 1975), all applicants for registration to import a basic 
class of any controlled substance in Schedule I or II are and will 
continue to be required to demonstrate to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: February 24, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-5266 Filed 3-2-95; 8:45 am]
BILLING CODE 4410-09-M
#### SAMUEL A. BATCHELOR et al. v. AMERICAN NATIONAL INSURANCE COMPANY, OF GALVESTON, TEXAS.

(Filed 18 February, 1931.)

Insurance H d — Insured is entitled to difference between cash value of policy and outstanding loan thereon as of date of notice to cancel.

The holder of a life insurance policy who has borrowed money thereon, upon giving notice to- the insurer to cancel the policy, is entitled only to receive the difference between the cash surrender value of the policy and the outstanding policy loan, and it is error for the trial judge to direct a verdict in a larger sum.

*347Appeal by defendant from *Granmer, J.,*at November Term, 1930, of Nash.

Civil action to recover the difference between the cash surrender value of a policy of life insurance and the outstanding policy loan, which difference, on 23 September, 1929, the annual premium date of said policy, amounted to $50.85.

It appears from the record that, after some correspondence between the parties as to the better course to pursue, the plaintiffs finally notified the defendant on 19 November, 1929, of their intention to surrender said policy and mailed release to that effect on said date.

Under the automatic premium-loan provision of said policy, the net cash value of the jmlicy would have been consumed on 26 November, 1929, but not before.

From a directed verdict in favor of the plaintiffs for $50.85, the defendant appeals, assigning errors.

*D. W. Perry for plaintiffs.*

*J. A. Edgerton and T. T. Thorne for*defendant.,

Stacy, O. J.,

after stating the case: Plaintiffs are entitled to recover the difference, if any, between the cash surrender value of the policy and the outstanding policy loan on the date the defendant received notice of intention to surrender, but no more. It was error, therefore, to direct a verdict for a larger sum.

New trial.
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 20
- 0332 STATE OF MONTANA,

Plaintiff and Appellee,
v. JOSHUA PAUL CORRIHER ,

Defendant and Appellant
.

**ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including February 26 , 2021 , within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Beth Baker Justice, Montana Supreme Court January 20 2021

01/20/2021

Case Number: DA 20-0332